This review is a summary of a recent speaker event held at ACD 2018 Gold Coast on developments in urticaria management and long-term data of secukinumab in psoriasis.
The first talk outlined current developments in the management of chronic spontaneous urticaria and the second talk focused on long-term data on secukinumab in patients with moderate-to-severe psoriasis. Both talks were given by Dr Papp, a practicing dermatologist from Ontario, Canada.
Please login below to download this issue (PDF)